FATE ▲ +1.4% - Fate Therapeutics, Inc. $FATE - Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026 26-OCT-2026 07:00 AM ET